(Q45296591)

11 December 2017

title

Tryptophan metabolism and oxidative stress in patients with Huntington's disease (English)

1 reference

11 December 2017

0 references

0 references

6

1 reference

11 December 2017

N Stoy

1

1 reference

11 December 2017

G M Mackay

2

1 reference

11 December 2017

C M Forrest

3

1 reference

11 December 2017

J Christofides

4

1 reference

11 December 2017

M Egerton

5

1 reference

11 December 2017

L G Darlington

7

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Journal of Neurochemistry

11 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 December 2017

volume

93

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

611-623

1 reference

Huntingtin aggregation and toxicity in Huntington's disease

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

NMDA receptor function in mouse models of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Parameters of inflammation and infection in a community based case-control study of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Early kynurenergic impairment in Huntington's disease and in a transgenic animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Activated immune system in patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Huntington's disease and low tryptophan diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Differential complementary localization of metabolic enzymes for quinolinic acid in olfactory bulb astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Early and progressive accumulation of reactive microglia in the Huntington disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Transgenic models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

II. Excitotoxic models for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: evidence that basal ganglia modulate sensory cortical input

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Kynurenines in the CNS: from endogenous obscurity to therapeutic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Endogenous kynurenines as targets for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Impaired synaptic plasticity in mice carrying the Huntington's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03070.X

10.1111/J.1471-4159.2005.03070.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference